TickerFactsScreenerDevelopers

Sarepta Therapeutics, Inc. (SRPT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

1980: $02008: $11.19M2009: $48.27M2010: $33.59M2011: $39.90M2012: $187.66M2013: $256.96M2014: $73.55M2015: $80.30M2016: $122.42M2017: $599.69M2018: $370.83M2019: $835.08M2020: $1.50B2021: $2.12B2022: $966.78M2023: $428.43M2024: $1.10B2025: $801.28M$801.28M
1980Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$801.28M-27.4%
2024$1.10B+157.5%
2023$428.43M-55.7%
2022$966.78M-54.3%
2021$2.12B+40.8%
2020$1.50B+79.9%
2019$835.08M+125.2%
2018$370.83M-38.2%
2017$599.69M+389.9%
2016$122.42M+52.4%
2015$80.30M+9.2%
2014$73.55M-71.4%
2013$256.96M+36.9%
2012$187.66M+370.3%
2011$39.90M+18.8%
2010$33.59M-30.4%
2009$48.27M+331.3%
2008$11.19M—
1980$0—